skip to main content

Semaglutide nausea — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyEndocrine TherapeuticsSemaglutide nauseaGPhC CRA

A patient starting semaglutide has nausea and early satiety but no severe abdominal pain or persistent vomiting. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Eat smaller meals and seek help for severe abdominal pain or persistent vomiting

This scenario assesses Semaglutide nausea in a UK pharmacy practice context. GLP-1 receptor agonists commonly cause nausea, while severe symptoms may suggest pancreatitis or dehydration. The best answer is Eat smaller meals and seek help for severe abdominal pain or persistent vomiting because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: BNF